Orlistat Medications

Orlistat is a lipase inhibitor medication used to promote weight loss by reducing the absorption of fats from the diet in the intestines.

Xenical

Orlistat

$0.81 per pill

60 | 120mg

Select pack

About Orlistat Weight Management

Orlistat is a gastrointestinal lipase inhibitor approved for long-term weight management in adults with a body-mass index (BMI) of 30 kg/m² or higher, or a BMI of 27 kg/m² with at least one obesity-related risk factor such as hypertension or dyslipidaemia. Belonging to the class of pancreatic lipase inhibitors, Orlistat reduces the breakdown and subsequent absorption of dietary fat by approximately 30 %, creating a calorie deficit that supports weight loss when combined with a reduced-calorie, low-fat diet. The most widely recognised brand names are Xenical, a 120 mg tablet, and Alli, a 60 mg over-the-counter formulation. Both branded and generic versions are stocked by our online pharmacy, offering a cost-effective route to access this therapy across Australia.

What is Orlistat?

Orlistat is classified as a reversible inhibitor of gastric and pancreatic lipases, the enzymes responsible for hydrolysing triglycerides into absorbable free fatty acids. The Therapeutic Goods Administration (TGA) granted approval for Orlistat in 1998 for the management of obesity, following earlier endorsement by the U.S. Food and Drug Administration (FDA) in 1999. Since then, the indication has been expanded to include patients with a BMI ≥ 27 kg/m² who present additional cardiovascular risk factors. By binding to the active site of lipases, Orlistat prevents the enzymatic cleavage of dietary fats, allowing up to one-third of ingested triglycerides to pass unchanged through the gastrointestinal tract. The drug is available as a 120 mg tablet (Xenical) and a 60 mg tablet (Alli), both of which can be purchased from our pharmacy service in generic form at a lower price point.

How Orlistat Works

Mechanism of Action

Orlistat forms a covalent bond with the serine residue in the active centre of gastric and pancreatic lipases. This interaction blocks the enzyme’s ability to hydrolyse triglycerides, so dietary fat remains in its intact form and is excreted in the stool. The inhibition is localised to the intestinal lumen and does not enter systemic circulation, which limits systemic side effects.

Therapeutic Effects

The reduction in fat absorption translates into a daily caloric deficit of roughly 300 kcal when a typical Western diet is followed. Clinical studies published in The New England Journal of Medicine reported an average additional weight loss of 5-10 % of baseline body weight after one year of therapy, compared with diet alone. The modest weight reduction improves insulin sensitivity, lowers LDL-cholesterol, and can modestly decrease systolic blood pressure, contributing to overall cardiovascular risk reduction.

Onset and Duration

Fat malabsorption becomes evident within the first few days of treatment, often manifesting as oily spotting or increased flatulence. The therapeutic effect on weight is cumulative; most patients observe a measurable decline in body weight after 4-6 weeks, with continued loss up to 12 months if adherence to a low-fat diet is maintained. The enzyme inhibition persists for the duration of each dose, and the drug is eliminated unchanged in the feces within 24 hours.

Approved Uses and Applications

Approved Indications

Management of obesity in adults with BMI ≥ 30 kg/m².
Adjunct therapy for adults with BMI ≥ 27 kg/m² plus hypertension, type 2 diabetes, or dyslipidaemia.
Long-term weight-maintenance after an initial weight-loss phase, as endorsed by the TGA and EMA.

Off-Label Uses

Orlistat has been investigated for the treatment of non-alcoholic fatty liver disease (NAFLD) and for modest improvements in metabolic syndrome components. While several small trials suggest a reduction in hepatic steatosis, these applications remain unapproved by regulatory agencies and should be considered experimental.

Clinical Efficacy

In a multicentre trial involving 3,000 participants, Lancet reported that patients receiving Orlistat lost an average of 7.5 % of baseline weight after 12 months, versus 3.5 % in the control group. The same study noted a 12 % greater reduction in LDL-cholesterol and a 5 % improvement in fasting glucose. These outcomes underscore the drug’s role as a clinically meaningful adjunct to lifestyle modification.

Buying Orlistat from Our Online Pharmacy

Why Choose Our Service

Our online pharmacy bridges the gap for Australians who encounter limited stock or high out-of-pocket costs at brick-and-mortar pharmacies. By sourcing directly from licensed international distributors, we ensure authentic, WHO-certified products while maintaining competitive pricing.

Brand Names and Generic Options

Xenical 120 mg (branded) - premium formulation.
Alli 60 mg (branded, lower dose).
Generic Orlistat 120 mg - cost-saving alternative with identical bio-equivalence.
Generic Orlistat 60 mg - suitable for patients preferring the over-the-counter strength.

Quality & Safety

We partner with pharmacies that operate under stringent regulatory frameworks, adhering to TGA-mandated Good Manufacturing Practice and WHO standards. Every batch undergoes third-party verification before dispatch.

Pricing & Access

Our platform offers a 10 % discount on all repeat orders, making long-term therapy financially sustainable. Bulk purchase options further reduce the per-tablet cost, supporting adherence over the recommended 12-month treatment window.

Discreet Delivery

Orders ship via express (≈ 7 days) or standard (≈ 3 weeks) services, packaged in unmarked boxes to protect privacy. Tracking information is provided at the time of dispatch.

Dosing, Formulations & Administration

Available Formulations

Orlistat is supplied as oral tablets in 60 mg and 120 mg strengths. Both strengths are film-coated for easy swallowing and are stable at room temperature.

Typical Dosing Ranges

For adults undergoing weight-loss therapy, clinicians often initiate treatment with one 120 mg tablet taken with each main meal that contains fat, up to three tablets per day. In the lower-dose regimen, a 60 mg tablet may be used with each meal, particularly for patients who experience gastrointestinal side effects. Dose adjustments are guided by clinical response and tolerability.

Administration Guidelines

Take the tablet during or up to one hour after a meal that contains fat; if a meal is missed or is low-fat, the dose should be omitted.
A daily multivitamin containing fat-soluble vitamins (A, D, E, K) is recommended to offset reduced absorption.
Avoid high-fat meals (> 30 % of total calories) to minimise oily spotting and fecal urgency.

A qualified healthcare professional must determine the exact regimen based on individual health status, concomitant medications, and dietary habits.

Safety Profile & Considerations

Common Side Effects

Oily spotting or flatus with discharge (reported in > 10 % of users).
Fecal urgency and increased stool frequency (≈ 8 %).
Mild abdominal cramping (≈ 5 %).
Reduced absorption of fat-soluble vitamins, mitigated by supplemental multivitamins.

These effects are usually transient and lessen as the gastrointestinal tract adapts to reduced fat absorption.

Serious Adverse Events

Rare cases of severe hepatic injury and acute pancreatitis have been documented. Immediate medical evaluation is warranted if jaundice, dark urine, or persistent abdominal pain develop.

Contraindications

Chronic malabsorption syndromes (e.g., cystic fibrosis, short-bowel syndrome).
Cholestasis or active gallbladder disease.
Pregnancy or breastfeeding, due to potential impact on fetal nutrient supply.

Drug Interactions

Cyclosporine: reduced absorption may lower immunosuppressive efficacy.
Warfarin: altered vitamin K levels can affect anticoagulation control.
Levothyroxine: concurrent use may require dose adjustment because of impaired absorption of the hormone.

Patients should disclose all prescription, over-the-counter, and herbal products to their clinician.

Special Populations

Older adults: Age-related reductions in renal and hepatic function may necessitate closer monitoring of vitamin levels.
Renal or hepatic impairment: No dose reduction is required, but clinicians should assess baseline liver enzymes periodically.
Pregnancy & lactation: Use is contraindicated; weight-management strategies should focus on diet and exercise under medical supervision.

Professional guidance is essential to balance efficacy with safety across diverse patient groups.

Frequently Asked Questions

How does Orlistat differ from Alli? Orlistat is the active ingredient in both products; the primary distinction lies in dosage. Alli contains 60 mg per tablet, intended for over-the-counter use, while Xenical provides 120 mg per tablet, typically prescribed for more pronounced weight-loss goals.
How long does Orlistat take to work? Gastrointestinal side effects appear within days, indicating enzyme inhibition. Noticeable weight loss generally emerges after 4-6 weeks of consistent use combined with a reduced-fat diet, with continued progress up to 12 months.
What should I do if I experience oily spotting from Orlistat? Reduce dietary fat intake to less than 30 % of total calories per meal and ensure the multivitamin supplement is taken at a different time of day. Persistent symptoms should be discussed with a healthcare professional.
Can I take Orlistat with a high-fat meal? The drug is most effective when taken with meals containing fat; however, excessive fat (> 30 % of calories) increases the likelihood of gastrointestinal side effects without enhancing weight loss.
Is Orlistat safe for long-term use? Long-term studies spanning up to four years have shown sustained weight reduction and stable safety parameters when patients adhere to vitamin supplementation and regular monitoring. Individual risk factors must still be evaluated by a clinician.
What foods should I avoid with Orlistat? Limit fried foods, full-fat dairy, fatty meats, and oil-rich sauces. Emphasise lean proteins, whole grains, fruits, and vegetables to stay within the recommended fat threshold.
Does Orlistat affect the absorption of other medications? Yes; drugs that rely on fat for absorption, such as cyclosporine and levothyroxine, may have reduced bioavailability. Separate dosing times (at least 2 hours apart) can mitigate this interaction.
Can I use Orlistat while taking a multivitamin? A daily multivitamin containing vitamins A, D, E, and K is recommended to compensate for decreased absorption. The supplement should be taken with a low-fat meal or at a different time than Orlistat.
What information should I provide my doctor when discussing Orlistat?
- Complete medical history, including any liver, gallbladder, or gastrointestinal disorders.
- Full list of current medications, supplements, and over-the-counter products.
- Recent weight-loss attempts, dietary patterns, and physical activity level.
- Specific treatment goals and any concerns about side effects or drug interactions.

Disclaimer

The information provided about Orlistat is for general knowledge only. It does not replace professional medical consultation or the official prescribing information for medications containing this ingredient. All treatment decisions, including dosing, formulation selection, and monitoring, should be made under the supervision of a qualified healthcare provider who can assess individual medical history, current medications, and specific health needs. We assume all readers are responsible adults capable of making informed decisions about their health. Our online pharmacy offers access to medications containing Orlistat for individuals who may have limited availability through traditional pharmacies, insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication containing Orlistat.